ARCHIVES

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

Bills To Lift $50 Cap On Mammography Will Be Introduced

February 10, 1989

Obituary: Paul Rogers, Former Congressman, Instrumental In National Cancer Act Passage.

October 17, 2008

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003

HHS Proposes Stronger Health Warnings On Cigarette Packages, Ads

November 12, 2010

Investigator Initiated Clinical Research Gets More For Less Money, Carbone Contends

April 13, 1979